WHO Raises Warning Over Critical Scarcity of Obesity Medications
Less than a tenth of patients eligible to benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it releases its first advice on the drugs.
With more than one billion people worldwide now obese, it is calling for increased and just availability to this class of drugs.
Based on estimates, over two billion will be obese by 2030 if no action is taken.
"The latest guidelines affirms that excess weight is a chronic disease that can be addressed with thorough and ongoing treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and supply-chain constraints are major hurdles to broad availability to the treatments that can assist patients in reducing substantial weight, says the organization.
Weight-Loss Drug Shortage
Despite the present most favorable outlook, the supply of these medications would only suffice for approximately 100 million people – less than 10% of those who need them, as stated by the health organization.
The advice encourages countries and companies to widen availability, via approaches such as voluntary licensing.
The intellectual property rights on the active ingredient – the core ingredient of a leading brand – is scheduled to end in multiple nations in 2026.
The Way Weight-Loss Drugs Operate
These medications replicate a biological compound to reduce digestion speed, reduce hunger and increase feelings of fullness so users reduce food intake.
Individuals commonly see weight reduction in the initial weeks of commencing the once-weekly jabs.
Evidence points to patients may regain a significant portion within a year of discontinuing the medication, because their typical appetite come back.
Being above a healthy weight elevates your likelihood for experiencing health problems, such as type 2 diabetes, heart disease, brain attack, and some cancers.
Excess weight affects individuals in countries worldwide and was linked to over three and a half million deaths worldwide in 2024, according to the health agency.
